AVNS

Avanos Medical, Inc.

19.14

Top Statistics
Market Cap 879 M Forward PE 11.48 Revenue Growth -0.50 %
Current Ratio 2.22 Trailing PE 40.72 Earnings Growth 0.00 %
Profit Margins 2.30 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 9.72 Enterprise / Revenue 1.46 Price To Sales Trailing12 Months 1.29
Profitability
Profit Margins 2.30 % Operating Margins 9.68 %
Balance Sheet
Total Cash 89 M Total Cash Per Share 1.94 Total Debt 202 M
Total Debt To Equity 16.44 Current Ratio 2.22 Book Value Per Share 26.73
All Measures
Short Ratio 214.00 % Message Board Id finmb_251719973 Shares Short Prior Month 754811
Return On Equity 0.0177 City Alpharetta Uuid 072d122b-2f4d-30a8-8d4c-00fcd10638d6
Previous Close 19.16 First Trade Date Epoch Utc 1 B Book Value 26.73
Beta 0.9250 Total Debt 202 M Volume 158195
Price To Book 0.7160 Fifty Two Week Low 17.39 Total Cash Per Share 1.94
Total Revenue 681 M Shares Short Previous Month Date 1 B Target Median Price 22.50
Audit Risk 6 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins 9.68 % Target Mean Price 22.50 Net Income To Common 21 M
Ask 19.51 Short Percent Of Float 0.0172 Implied Shares Outstanding 46 M
Last Fiscal Year End 1 B Trailing Peg Ratio None Average Daily Volume10 Day 319690
Average Volume10days 319690 Total Cash 89 M Next Fiscal Year End 1 B
Revenue Per Share 14.79 Held Percent Insiders 0.0295 Ebitda Margins 15.00 %
Trailing PE 40.72 Date Short Interest 1 B Most Recent Quarter 1 B
Share Holder Rights Risk 7 Regular Market Previous Close 19.16 Target Low Price 20.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 21.44 Open 19.31
Free Cashflow 140 M State GA Dividend Yield 0.00 %
Return On Assets 0.0208 Time Zone Short Name EST Board Risk 1
Trailing Eps 0.4700 Day Low 19.11 Address1 5405 Windward Parkway
Shares Outstanding 45 M Compensation Risk 2 Price Hint 2
Target High Price 25.00 Website https://avanos.com 52 Week Change -0.1118
Average Volume 251556 Forward Eps 1.67 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 103.80 % Is_sp_500 False
Regular Market Day High 19.48 Profit Margins 2.30 % Debt To Equity 16.44
Fifty Two Week High 25.36 Day High 19.48 Shares Short 552329
Regular Market Open 19.31 Industry Key medical-devices Bid 10.45
Earnings Growth 0.00 % Enterprise To Revenue 1.46 Revenue Growth -0.50 %
Shares Percent Shares Out 0.0120 Operating Cashflow 55 M Currency USD
Time Zone Full Name America/New_York Market Cap 879 M Is_nasdaq_100 False
Zip 30004 Quote Type EQUITY Industry Medical Devices
Long Name Avanos Medical, Inc. Overall Risk 4 Regular Market Day Low 19.11
Held Percent Institutions 0.9610 Current Price 19.14 Address2 Suite 100 South
Enterprise To Ebitda 9.72 Financial Currency USD Current Ratio 2.22
Gross Margins 55.51 % Industry Disp Medical Devices Number Of Analyst Opinions 2
Country United States Float Shares 41 M Two Hundred Day Average 20.86
Governance Epoch Date 1 B Enterprise Value 993 M Price To Sales Trailing12 Months 1.29
Forward PE 11.48 Regular Market Volume 158195 Ebitda 102 M
Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems.

In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions.

It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors.

The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018.

Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.